Psilocybin Research for Substance Use Disorders

[madman]

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Accept third party cookies

Recorded Grand Rounds from Johns Hopkins Psychiatry and Behavioral Sciences. Sandeep Nayak, M.D. presented on the topic “Psilocybin for substance use disorders: an overview of current research and future directions at Hopkins” (November 20, 2023). Please note that the window for earning CME credit has expired. #Psychedelics #JohnsHopkins #SUD #Psychiatry https://www.hopkinspsychedelic.org/

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

Opioid-induced hypogonadism

Testosterone deficiency, the unrecognized consequence of the opioid epidemic in men (2022) Janine David, GP and Associate Specialist in Andrology; Mike Kirby, Editor Testosterone deficiency resulting from chronic opioid use can have a profound effect on health and quality of life, but it often...

www.excelmale.com